Literature DB >> 16239364

Drug utilization in the pediatric intensive care unit: monitoring prescribing trends and establishing prioritization of pharmacotherapeutic evaluation of critically ill children.

Athena F Zuppa1, Peter C Adamson, John T Mondick, Lauren A Davis, Deborah A Maka, Mahesh Narayan, Charles Nicholson, Dimple Patel, Kathryn R Collison, Jeffrey S Barrett.   

Abstract

The primary objective of this study was to characterize the drug exposure for children hospitalized in the authors' institution's pediatric intensive care unit for the year 2002. Secondary objectives included the examination of drug utilization differences among various age criteria and the suitability of the most prevalent resources for pediatric dosing guidance. Many of the most commonly prescribed agents in the pediatric intensive care unit fall into the broad categories of pain management/sedation and anti-infectives. Based on the generally narrow windows afforded by each of these drug classes, it is obvious that more, well-defined investigations in critically ill children are warranted. The existing dosing guidance for many of these agents is neither generalizable nor sufficient to accommodate the diversity in pediatric intensive care unit patients, and the current drug monographs fall short of any practical dosing information.

Entities:  

Mesh:

Year:  2005        PMID: 16239364     DOI: 10.1177/0091270005280966

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  8 in total

1.  Patterns of Off-Label Prescribing in the Pediatric Intensive Care Unit and Prioritizing Future Research.

Authors:  Angela S Czaja; Pamela D Reiter; M Lynn Schultz; Robert J Valuck
Journal:  J Pediatr Pharmacol Ther       Date:  2015 May-Jun

2.  Midazolam Dose Optimization in Critically Ill Pediatric Patients With Acute Respiratory Failure: A Population Pharmacokinetic-Pharmacogenomic Study.

Authors:  Athena F Zuppa; Daniela J Conrado; Nicole R Zane; Martha A Q Curley; Jonathan Bradfield; Hakon Hakonarson; Madeleine S Gastonguay; Ganesh Moorthy; Janice Prodell; Marc R Gastonguay
Journal:  Crit Care Med       Date:  2019-04       Impact factor: 7.598

3.  Face and content validity of variables associated with the difficult-to-sedate child in the paediatric intensive care unit: A survey of paediatric critical care clinicians.

Authors:  Ruth M Lebet; Lisa A Asaro; Athena F Zuppa; Martha A Q Curley
Journal:  Aust Crit Care       Date:  2018-03-19       Impact factor: 2.737

4.  Epidemiology of Polypharmacy and Potential Drug-Drug Interactions Among Pediatric Patients in ICUs of U.S. Children's Hospitals.

Authors:  Dingwei Dai; James A Feinstein; Wynne Morrison; Athena F Zuppa; Chris Feudtner
Journal:  Pediatr Crit Care Med       Date:  2016-05       Impact factor: 3.624

5.  Prescribing habits and caregiver satisfaction with resources for dosing children: rationale for more informative dosing guidance.

Authors:  Jeffrey S Barrett; Mahesh Narayan; Dimple Patel; Athena F Zuppa; Peter C Adamson
Journal:  BMC Pediatr       Date:  2011-04-02       Impact factor: 2.125

6.  Medications for Children Receiving Intensive Care: A National Sample.

Authors:  Julia A Heneghan; Eduardo A Trujillo Rivera; Qing Zeng-Treitler; Farhana Faruqe; Hiroki Morizono; James E Bost; Murray M Pollack; Anita K Patel
Journal:  Pediatr Crit Care Med       Date:  2020-09       Impact factor: 3.971

7.  Patterns of Medication Exposure in Children on Extracorporeal Membrane Oxygenation: A Step in Prioritizing Future Pharmacologic Studies.

Authors:  Céline Thibault; Hailey Collier; Maryam Y Naim; Jenna Heichel; Emily Schwartz; Athena F Zuppa
Journal:  Crit Care Explor       Date:  2019-09-16

8.  Pragmatic estimates of the proportion of pediatric inpatients exposed to specific medications in the USA.

Authors:  Chris Feudtner; Dingwei Dai; Jennifer Faerber; Talene A Metjian; Xianqun Luan
Journal:  Pharmacoepidemiol Drug Saf       Date:  2013-05-23       Impact factor: 2.890

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.